MacroGenics, Inc. (MGNX) vs Sionna Therapeutics, Inc. (SION)
MacroGenics, Inc. and Sionna Therapeutics, Inc. are both Biotechnology companies. MacroGenics, Inc. and Sionna Therapeutics, Inc. are of similar size ($242.1M and $241.9M). Sionna Therapeutics, Inc. has the higher net margin (0.00% vs −7.97%) and the lower return on invested capital (−125.0% vs 0.00%). Across the 12 metrics below, Sionna Therapeutics, Inc. leads on 8 and MacroGenics, Inc. on 4.
Valuation
Profitability
| Metric | MGNX | SION | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.07% | — | 65.16% |
| Operating margin | (18.73%) | 0.00% | 0.00% |
| Net margin | (7.97%) | 0.00% | 0.00% |
| Free cash flow margin | (35.80%) | 0.00% | 0.00% |
| Return on equity | (32.61%) | (32.34%) | (57.72%) |
| Return on assets | (4.94%) | (30.66%) | (49.22%) |
| Return on invested capital | 0.00% | (125.00%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack